Back
ARMOUR Residential REIT Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
45
ARR
ARMOUR Residential REIT
Last Price:
19.41
Seasonality Move:
-2.03%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Sell
45
ARMOUR Residential REIT (ARR)
is a Sell
Is ARMOUR Residential REIT a Buy, Sell or Hold?
- The current ARMOUR Residential REIT [ARR] share price is $19.52. The Score for ARR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ARR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARR Stock Price Chart
What is ARMOUR Residential REIT's stock price today?
-
The ARMOUR Residential REIT share price today is $19.52
The current trend is moderately bullish and ARR is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
ARR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 54.13 | Buy |
Chaikin Money Flow: | -350068 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.01 - 19.57) | Buy |
Bollinger Bands (100): | (18.56 - 19.56) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 45.16 | Sell |
Chaikin Money Flow: | -377368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.89 - 42.13) | Sell |
Bollinger Bands (100): | (40.93 - 48.81) | Sell |
ARR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.43 | Buy |
20-day SMA: | 19.34 | Buy |
50-day SMA: | 18.96 | Buy |
200-day SMA: | 19.01 | Buy |
8-day EMA: | 19.43 | Buy |
20-day EMA: | 19.34 | Buy |
50-day EMA: | 19.18 | Buy |
200-day EMA: | 20.13 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.13 | Sell |
20-day SMA: | 40.38 | Sell |
50-day SMA: | 41.72 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.68 | Sell |
20-day EMA: | 40.43 | Sell |
50-day EMA: | 41.92 | Sell |
200-day EMA: | 43.42 | Sell |
ARMOUR Residential REIT Earnings Growth & ARR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.81 per share, and an increase next year of $0.37 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
ARMOUR Residential REIT Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |